Q2 2026 Holdings
Filed 2026-08-14 | 41 holdings | $4.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $899.1M | 7,679,684 | 19.6% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $613.0M | 18,088,902 | 13.3% |
| Erasca Inc(ERAS) | COM | 29479A108 | $457.5M | 24,975,188 | 10.0% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $367.2M | 6,652,013 | 8.0% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $258.9M | 9,874,511 | 5.6% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $185.4M | 9,939,447 | 4.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $178.9M | 481,307 | 3.9% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $150.2M | 5,032,915 | 3.3% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $135.3M | 12,466,489 | 2.9% |
| Palvella Therapeutics Inc NE(PVLA) | COM | 697947109 | $134.8M | 882,400 | 2.9% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $115.3M | 1,548,139 | 2.5% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $99.1M | 1,354,852 | 2.2% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $98.8M | 1,159,879 | 2.2% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $70.0M | 3,153,082 | 1.5% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $60.1M | 225,155 | 1.3% |
| Savara Inc(SVRA) | COM | 805111101 | $59.9M | 9,720,852 | 1.3% |
| Parabilis Medicines Inc(PBLS) | COM | 698955101 | $52.6M | 1,920,805 | 1.1% |
| Aura Biosciences Inc(AURA) | COM | 05153U107 | $50.4M | 7,100,000 | 1.1% |
| Achieve Life Science Inc(ACHV) | COM | 004468500 | $49.7M | 7,614,836 | 1.1% |
| VOR Biopharma Inc(VOR) | COM NEW | 929033207 | $46.8M | 2,543,939 | 1.0% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $46.7M | 22,446,668 | 1.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $45.9M | 728,644 | 1.0% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $40.1M | 4,009,240 | 0.9% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $36.7M | 700,647 | 0.8% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $36.4M | 1,438,198 | 0.8% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $36.1M | 1,902,320 | 0.8% |
| Mannkind Corp(MNKD) | COM NEW | 56400P706 | $28.1M | 6,600,000 | 0.6% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $26.2M | 1,809,854 | 0.6% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $26.1M | 4,925,374 | 0.6% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $26.0M | 3,750,000 | 0.6% |
| Kailera Therapeutics Inc(KLRA) | COMMON STOCK | 482931102 | $24.2M | 1,100,000 | 0.5% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $24.2M | 1,000,000 | 0.5% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $22.5M | 4,824,725 | 0.5% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $19.0M | 1,015,693 | 0.4% |
| Evolus Inc(EOLS) | COM | 30052C107 | $18.3M | 2,630,665 | 0.4% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $15.4M | 484,782 | 0.3% |
| Valneva SE(VALN) | SPONSORED ADS | 92025Y103 | $12.0M | 2,291,666 | 0.3% |
| Newamsterdam Pharma Company | *W EXP 99/99/999 | N62509117 | $10.7M | 500,333 | 0.2% |
| Autolus Therapeutics LTD(AUTL) | SPON ADS | 05280R100 | $7.1M | 4,447,910 | 0.2% |
| Xilio Therapeutics Inc(XLO) | COM | 98422T209 | $4.0M | 422,505 | 0.1% |
| Ibio Inc(IBIO) | COM NEW | 451033708 | $3.4M | 1,953,467 | 0.1% |